The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve ...

One ALS patient received TRE-515 under the FDA program last year, and early signs suggest the therapy may help stabilize ...

Brooke Eby, a writer, speaker, and social media creator who lives with ALS, has been named ALS Network's Advocate of the Year. Through her advocacy work, Eby has increased awareness and raised more ...

The new project combines clinical data with advanced analytics and artificial intelligence in an effort to create ...

Every few months for the past three years, Jeff Vierstra has been receiving infusions in his spine that target and disable a ...

"CBS Saturday Morning" looks at an experimental treatment for amyotrophic lateral sclerosis, or Lou Gehrig's disease, that is ...

ALS is life‑changing, but new treatments, specialized care, and innovative research are bringing real hope. See how advances at University of Utah Health are shaping the future of ALS care.

A scientist diagnosed with an ultra-rare form of ALS linked to a CHCHD10 gene mutation is now enrolled in a one-of-a-kind ...

Elon Musk highlights Neuralink’s latest breakthrough as ALS patient Kenneth Shock regains ability to communicate. The brain ...

Earlier bedtime and wake time and regular physical activity are associated with a significant reduction in ALS risk, a new ...